Kurpas, A.; Supel, K.; Wieczorkiewicz, P.; Bodalska Duleba, J.; Zielinska, M.
Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients—Cardiologists Be Aware. Metabolites 2022, 12, 498.
https://doi.org/10.3390/metabo12060498
AMA Style
Kurpas A, Supel K, Wieczorkiewicz P, Bodalska Duleba J, Zielinska M.
Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients—Cardiologists Be Aware. Metabolites. 2022; 12(6):498.
https://doi.org/10.3390/metabo12060498
Chicago/Turabian Style
Kurpas, Anna, Karolina Supel, Paulina Wieczorkiewicz, Joanna Bodalska Duleba, and Marzenna Zielinska.
2022. "Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients—Cardiologists Be Aware" Metabolites 12, no. 6: 498.
https://doi.org/10.3390/metabo12060498
APA Style
Kurpas, A., Supel, K., Wieczorkiewicz, P., Bodalska Duleba, J., & Zielinska, M.
(2022). Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients—Cardiologists Be Aware. Metabolites, 12(6), 498.
https://doi.org/10.3390/metabo12060498